Novo Nordisk will continue to sell Wegovy on other telehealth platforms that "share our commitment to patient safety," said Dave Moore, executive vice president at Novo Nordisk, in the company's statement
"I do worry about what's going to happen in a month." The massive popularity of Ozempic, Wegovy, Mounjaro and Zepbound has meant the drugs have been in and out of short supply for more than a year, as the drugs' makers have been struggling to keep up with skyrocketing demand
Schedule your consultation today to see if a compounded GLP-1 is right for you.
The concern is valid, given that these medications directly affect pancreatic function
Market Concentration & Characteristics: The GLP-1 Receptor Agonist Market exhibits high market concentration, with a few established players accounting for the majority of global revenue
At just $99/month (cancel anytime), our program includes: Medical Provider Consultations : Expert prescriptions and ongoing medical support, in-person or remotely